Tonghui Ma
22 Papers
3 Citations
Tonghui Ma is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
TL;DR: The value of next‐generation sequencing (NGS) for cancer diagnosis in indeterminate thyroid nodules is evaluated.
19
Association of KMT2C/D loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer
Ruiqi Liu,Y. Niu,Chao Liu,Xin Zhang,Jinku Zhang,Min Shi,Wenbo Zou,Binbin Gu,Honglin Zhu,Danhua Wang,Hongling Yuan,Wei Li,Dandan Zhao,Qiaosong Zheng,Rong Li,Weiping Chen,Tonghui Ma,Yanqiao Zhang +17 more
TL;DR: Wang et al. as mentioned in this paper investigated the associations of KMT2C/D loss-of-function (LOF) variants with tumor mutation burden (TMB), MSI•H, PD•L1 expression, and clinical response to ICIs.
17
Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts
Ziyu Li,Yongning Jia,Honglin Zhu,Hongling Yuan,Xiaofang Xing,Yaqun Xin,Tonghui Ma,Fei Pang,Yan Zhang,Yingqi Hu,Shuqin Jia,Jiafu Ji +11 more
TL;DR: In this article, the authors developed a method that integrates MSI score, MMR mutation status and tumor mutation burden level to identify MSI status from next-generation sequencing (NGS) data.
12
Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A)
TL;DR: A locally advanced lung cancer patient with dMMR/MSI-H/TMB-H tumor and selective loss of PMS2 by immunohistochemistry was presented and the diagnosis of LS was made based on genetic analysis of this variant and literature review.
The effect of EGFR‐TKIs on survival in advanced non‐small‐cell lung cancer with EGFR mutations: A real‐world study
Xiaoqing Yu,J Si,Jingwen Wei,Yanling Wang,Yan Sun,Jianan Jin,Xiaoyan Zhang,Tonghui Ma,Zhengbo Song +8 more
TL;DR: In this article , the authors evaluated whether EGFR-TKI treatment confers survival benefits among advanced non-small-cell lung cancer (NSCLC) patients harboring EGFR mutations in the Chinese population.
5